Article
Telmisartan-Induced Alteration of Voltage-Gated Na<sup>+</sup> Currents: Integrated Experimental and In Silico Approaches
2026-03-06
Abstract excerpt
Telmisartan (TEL) is a non-peptide, orally administered antihypertensive agent primarily known as angiotensin II type 1 (AT1) blocker. In this review, we provide a detailed overview of how TEL modulates voltage-gated Na+ current (INa) and affects action potential (AP) firing behavior. TEL exerts differential stimulatory effects on the peak and late components of INa when subjected to brief depolarizing pulses acro...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 83515020-dba0-5bef-b00b-e2ae2428e599
- DOI
- 10.20944/preprints202603.0533.v1
